DRAFT REQUIREMENT FOR HIV VACCINE DESIGN AND DEVELOPMENT TEAMS

Release Date:  April 22, 1998

P.T.

NIAID DRAFT REQUIREMENT No. NIH-NIAID-99-18

National Institute of Allergy and Infectious Diseases

The highest priority of the Division of AIDS, National Institute of Allergy and
Infectious Diseases, NIH, is the discovery, development, and evaluation of
HIV/AIDS vaccines.  To augment the vaccine product pipeline, the upcoming HIV
Vaccine Design and Development Teams solicitation will seek to fund consortia of
scientists with development experience from industry and/or academia to take an
identified promising vaccine concept and develop it to product stage.  Up to $10
million per year will be made available to fund 1-5 projects.  Each contract is
anticipated to be a five-year cost-plus-award-fee completion type.

Examples of vaccine concepts include, but are not limited to: peptides, whole
killed virus, virus-like particles, live-attenuated virus, protein (recombinant
virus protein or cell/virus surface molecule complexes), and pseudovirions.

As provided for by FAR 5.205, entitled þSpecial Situations,þ a Draft Project
Requirement (i.e., a draft Work Statement, draft Technical Evaluation Criteria,
and draft Reporting Requirements) is available for review through the NIAID
Internet Home Page. The draft project requirement also includes Response
Guidelines. The NIAID is soliciting project interest, comments, and
recommendations on this draft project requirement in an effort to improve and
refine it prior to issuing a solicitation.  All responses are due to the NIAID
no later than Wednesday, May 6, 1998.  Proposals are not being solicited at this
time.

This draft project requirement is available electronically and may be accessed
through the NIAID Contract Management Branch (CMB) Home Page at the following
URL:  http://www.niaid.nih.gov/contract/rfp's/nih9918.htm.  The draft requirement
has been assigned reference number NIH-NIAID-99-18.  Proposals are not being
solicited at this time.

INQUIRIES

This is not a request for proposals.  Inquiries regarding this draft project
requirement may be directed to:

Paul D. McFarlane or Brenda J. Velez
Contract Management Branch
National Institute of Allergy and Infectious Diseases
6003 Executive Boulevard, Room 3C07, MSC 7610
Bethesda, MD  20892-7610
Telephone:  (301) 496-0349 or (301) 496-7117
Email:  pm24v@nih.gov or bv4y@nih.gov


Return to Volume Index

Return to NIH Guide Main Index


Office of Extramural Research (OER) - Home Page Office of Extramural
Research (OER)
  National Institutes of Health (NIH) - Home Page National Institutes of Health (NIH)
9000 Rockville Pike
Bethesda, Maryland 20892
  Department of Health and Human Services (HHS) - Home Page Department of Health
and Human Services (HHS)
  USA.gov - Government Made Easy


Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.